Treatment reduces lung damage and results in mild symptoms in a preclinical study. A novel decoy protein designed by Northwestern Medicine scientists fools SARS-Cov-2 by intercepting the spike of the coronavirus and rendering it impotent. The novel protein significantly reduced lung damage and…
Read more at SciTechDaily…
